Getinge reported a mixed Q3 22 update, beating estimates but trimming the FY22 outlook due to continuing supply chain bottlenecks and Covid-19 lockdowns in China, sending the stock down 4.8% at pixel time. Getinge now expects FY 22 organic sales to decline by 3-6% (vs in line previously). We expect the soft organic growth development to be offset by higher FX tailwinds, resulting in no significant change to our estimates.